Augmented reality-based sensory interaction device
Augmented reality-based sensory interaction device has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Feb 25, 2026: “Research on the effect of augmented reality based sensory interaction device in rehabilitation training of patients with chronic heart failure”.
1 paper studies it3 findingsUpdated
See all 1 papers on augmented reality-based sensory interaction device
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Post-intervention analysis revealed significant improvements in the intervention group across several parameters, including left ventricular ejection fraction (LVEF: 54.11% vs. 51.85%, P < 0.001)”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
What did studies of augmented reality-based sensory interaction device find?
3Studies of augmented reality-based sensory interaction device measured 3 outcomes: Minnesota Living With Heart Failure Questionnaire score, exercise capacity and left ventricular ejection fraction.
Minnesota Living With Heart Failure Questionnaire score
downin humans1
1 study
Minnesota Living With Heart Failure Questionnaire score
downin humans1
Augmented reality-based sensory interaction device decreases Minnesota Living With Heart Failure Questionnaire score in humans (chronic heart failure).
“MLHFQ scores decreased more substantially, indicating enhanced quality of life.”
Human trialchronic heart failurefour-weekn = 200
BMC cardiovascular disorders
More on Minnesota Living With Heart Failure Questionnaire score
Exercise capacity
upin humans1
1 study
Exercise capacity
upin humans1
Augmented reality-based sensory interaction device improves exercise capacity in humans (chronic heart failure) (392.14 m vs. 367.89 m).
“Exercise capacity, indicated by 6-minute walking distance (6MWD: 392.14 m vs. 367.89 m, P < 0.001), and GSES scores also improved significantly (25.14 vs. 23.82, P = 0.009).”
Human trialchronic heart failurefour-weekn = 200
BMC cardiovascular disorders
Left ventricular ejection fraction
upin humans1
1 study
Left ventricular ejection fraction
upin humans1
Augmented reality-based sensory interaction device improves left ventricular ejection fraction in humans (chronic heart failure) (54.11% vs. 51.85%).
“Post-intervention analysis revealed significant improvements in the intervention group across several parameters, including left ventricular ejection fraction (LVEF: 54.11% vs. 51.85%, P < 0.001)”
Human trialchronic heart failurefour-weekn = 200
BMC cardiovascular disorders